Standing on three legs: Antiviral activities of RIG-I against influenza viruses

Current Opinion in Immunology

Volumn 42, Issue , 2016, Pages 71-75

  Weber Gerlach, Michaela ^a   Weber, Friedemann ^b  

^a KYOTO UNIVERSITY   (Japan)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INFLAMMASOME; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA CONVERTING ENZYME; NONSTRUCTURAL PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN I; VIRUS RNA; INTERFERON; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; RARRES3 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR;

ANTIVIRAL ACTIVITY; HUMAN; INFLAMMATION; INFLUENZA A; INFLUENZA A VIRUS; INTERFERON INDUCTION; INTERFERON PRODUCTION; NONHUMAN; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; ANIMAL; GENETICS; IMMUNOLOGY; INFLUENZA; INNATE IMMUNITY; METABOLISM; MOUSE; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON TYPE I; MICE; ORTHOMYXOVIRIDAE INFECTIONS; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; RECEPTORS, PATTERN RECOGNITION; RECEPTORS, RETINOIC ACID; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84974846075     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.05.016     Document Type: Review

References (50)

1. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
2. Yoneyama M., Onomoto K., Jogi M., Akaboshi T., Fujita T. Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol 2015, 32:48-53.
3. Ahmad S., Hur S. Helicases in antiviral immunity: dual properties as sensors and effectors. Trends Biochem Sci 2015, 40:576-585.
4. Kohlway A., Luo D., Rawling D.C., Ding S.C., Pyle A.M. Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep 2013, 14:772-779.
5. Pham A.M., Santa Maria F.G., Lahiri T., Friedman E., Marie I.J., Levy D.E. PKR transduces MDA5-dependent signals for type I IFN induction. PLoS Pathog 2016, 12:e1005489.
6. Pichlmair A., Schulz O., Tan C.P., Rehwinkel J., Kato H., Takeuchi O., Akira S., Way M., Schiavo G., Sousa C.R.E. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J Virol 2009, 83:10761-10769.
7. Bruns A.M., Horvath C.M. LGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signaling. Cytokine 2015, 74:198-206.
8. Childs K.S., Randall R.E., Goodbourn S. LGP2 plays a critical role in sensitizing mda-5 to activation by double-stranded RNA. PLoS ONE 2013, 8.
9. Benitez A.A., Panis M., Xue J., Varble A., Shim J.V., Frick A.L., Lopez C.B., Sachs D., tenOever B.R. In vivo RNAi screening identifies MDA5 as a significant contributor to the cellular defense against influenza A virus. Cell Rep 2015, 11:1714-1726.
10. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
11. Onomoto K., Jogi M., Yoo J.S., Narita R., Morimoto S., Takemura A., Sambhara S., Kawaguchi A., Osari S., Nagata K., et al. Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS ONE 2012, 7:e43031.
12. Pflug A., Guilligay D., Reich S., Cusack S. Structure of influenza A polymerase bound to the viral RNA promoter. Nature 2014, 516:355-360.
13. Liu G., Park H.S., Pyo H.M., Liu Q., Zhou Y. Influenza A virus panhandle structure is directly involved in RIG-I activation and interferon induction. J Virol 2015, 89:6067-6079.
14. Weber M., Sediri H., Felgenhauer U., Binzen I., Banfer S., Jacob R., Brunotte L., Garcia-Sastre A., Schmid-Burgk J.L., Schmidt T., et al. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe 2015, 17:309-319.
15. Anchisi S., Guerra J., Mottet-Osman G., Garcin D. Mismatches in the influenza A virus RNA panhandle prevent retinoic acid-inducible gene I (RIG-I) sensing by impairing RNA/RIG-I complex formation. J Virol 2015, 90:586-590.
16. Davis W.G., Bowzard J.B., Sharma S.D., Wiens M.E., Ranjan P., Gangappa S., Stuchlik O., Pohl J., Donis R.O., Katz J.M., et al. The 3' untranslated regions of influenza genomic sequences are 5'ppp-independent ligands for RIG-I. PLoS ONE 2012, 7.
17. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., Sousa C.R.E. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
18. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
19. Baum A., Sachidanandam R., Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 2010, 107:16303-16308.
20. Saira K., Lin X., DePasse J.V., Halpin R., Twaddle A., Stockwell T., Angus B., Cozzi-Lepri A., Delfino M., Dugan V., et al. Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J Virol 2013, 87:8064-8074.
21. Killip M.J., Smith M., Jackson D., Randall R.E. Activation of the interferon induction cascade by influenza a viruses requires viral RNA synthesis and nuclear export. J Virol 2014, 88:3942-3952.
22. Weber M., Gawanbacht A., Habjan M., Rang A., Bomer C., Schmidt A.M., Veitinger S., Jacob R., Devignot S., Kochs G., et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
23. Liedmann S., Hrincius E.R., Guy C., Anhlan D., Dierkes R., Carter R., Wu G., Staeheli P., Green D.R., Wolff T., et al. Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions. Nat Commun 2014, 5:5645.
24. Osterlund P., Strengell M., Sarin L.P., Poranen M.M., Fagerlund R., Melen K., Julkunen I. Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry. J Virol 2012, 86:11183-11193.
25. Labadie K., Dos Santos Afonso E., Rameix-Welti M.A., van der Werf S., Naffakh N. Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology 2007, 362:271-282.
26. Li W., Chen H., Sutton T., Obadan A., Perez D.R. Interactions between the influenza A virus RNA polymerase components and retinoic acid-inducible gene I. J Virol 2014, 88:10432-10447.
27. Graef K.M., Vreede F.T., Lau Y.F., McCall A.W., Carr S.M., Subbarao K., Fodor E. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 2010, 84:8433-8445.
28. Iwai A., Shiozaki T., Kawai T., Akira S., Kawaoka Y., Takada A., Kida H., Miyazaki T. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 2010, 285:32064-32074.
29. Perez-Cidoncha M., Killip M.J., Oliveros J.C., Asensio V.J., Fernandez Y., Bengoechea J.A., Randall R.E., Ortin J. An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response. J Virol 2014, 88:4632-4646.
30. Marc D. Influenza virus non-structural protein NS1: interferon antagonism and beyond. J Gen Virol 2014, 95:2594-2611.
31. Schneider W.M., Chevillotte M.D., Rice C.M. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 2014, 32:513-545.
32. Bailey C.C., Huang I.C., Kam C., Farzan M. IFITM3 limits the severity of acute influenza in mice. PLoS Pathog 2012, 8:e1002909.
33. Everitt A.R., Clare S., Pertel T., John S.P., Wash R.S., Smith S.E., Chin C.R., Feeley E.M., Sims J.S., Adams D.J., et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012, 484:519-523.
34. Haller O., Staeheli P., Schwemmle M., Kochs G. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol 2015, 23:154-163.
35. Gao S., von der Malsburg A., Dick A., Faelber K., Schroder G.F., Haller O., Kochs G., Daumke O. Structure of myxovirus resistance protein A reveals intra- and intermolecular domain interactions required for the antiviral function. Immunity 2011, 35:514-525.
36. Manz B., Dornfeld D., Gotz V., Zell R., Zimmermann P., Haller O., Kochs G., Schwemmle M. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog 2013, 9:e1003279.
37. Xiao H., Killip M.J., Staeheli P., Randall R.E., Jackson D. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J Virol 2013, 87:13053-13058.
38. Zimmermann P., Manz B., Haller O., Schwemmle M., Kochs G. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol 2011, 85:8133-8140.
39. Khaperskyy D.A., Emara M.M., Johnston B.P., Anderson P., Hatchette T.F., McCormick C. Influenza A virus host shutoff disables antiviral stress-induced translation arrest. PLoS Pathog 2014, 10.
40. Gil J., Garcia M.A., Gomez-Puertas P., Guerra S., Rullas J., Nakano H., Alcami J., Esteban M. TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol 2004, 24:4502-4512.
41. Silverman R.H. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol 2007, 81:12720-12729.
42. Min J.Y., Krug R.M. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 2006, 103:7100-7105.
43. Sato S., Li K., Kameyama T., Hayashi T., Ishida Y., Murakami S., Watanabe T., Iijima S., Sakurai Y., Watashi K., et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 2015, 42:123-132.
44. Yao H., Dittmann M., Peisley A., Hoffmann H.H., Gilmore R.H., Schmidt T., Schmid-Burgk J.L., Hornung V., Rice C.M., Hur S. ATP-dependent effector-like functions of RIG-I-like receptors. Mol Cell 2015, 58:541-548.
45. Chan Y.K., Gack M.U. RIG-I works double duty. Cell Host Microbe 2015, 17:285-287.
46. Weber F. The catcher in the RIG-I. Cytokine 2015, 76:38-41.
47. Poeck H., Bscheider M., Gross O., Finger K., Roth S., Rebsamen M., Hannesschlager N., Schlee M., Rothenfusser S., Barchet W., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 2010, 11:63-69.
48. Pothlichet J., Meunier I., Davis B.K., Ting J.P., Skamene E., von Messling V., Vidal S.M. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog 2013, 9:e1003256.
49. Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., Guthrie E.H., Pickles R.J., Ting J.P. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
50. Thomas P.G., Dash P., Aldridge J.R., Ellebedy A.H., Reynolds C., Funk A.J., Martin W.J., Lamkanfi M., Webby R.J., Boyd K.L., et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30:566-575.